168飞艇正规平台, 幸运飞行艇官方开奖结果官网

View all news

19 May 2022

COVAX calls for urgent action to close vaccine equity gap

COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower-income countries

12 May 2022

DFC financing up to US$ 1 billion for Gavi COVID-19 vaccine and ancillary supply purchase and delivery

The White House today announced that US International Development Finance Corporation (DFC) and Gavi, the Vaccine Alliance have partnered to create the COVAX Rapid Financing Facility, which will provide up to US$ 1 billion to accelerate COVID-19…

27 April 2022

Amref health Africa appointed by Gavi as the new Civil Society Organisation (CSO) host

As part of this year’s World Immunisation Week, Gavi, the Vaccine Alliance, Amref Health Africa, and the Gavi Civil Society Organisation (CSO) Steering Committee announced a new partnership to harness the full potential of civil society to…

COVAX deliveries of COVID-19 vaccines

>1.5 bn COVAX vaccines shipped
OWP
144 participants

As of 20 May 2022

COVAX Facility

Gavi is co-leading COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. This involves coordinating the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.

Learn more

 

 

#VaccinesWork

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

168幸运飞行艇计划免费下载

View all stories

25 May 2022

What is behind the sudden international spread of monkeypox?

The virus may be exploiting a change in population behaviour and increased global travel but it can still be stopped from spreading further, say scientists.

25 May 2022

COVID-19 could derail SDGs for next five years – report

COVID-19 will remain uncontrolled in many countries unless coordinated action is taken, warn scientists. SDGs progress was already lagging before the pandemic. Inequities in all sectors must be addressed to avoid worst-case scenario. UN urged to…

25 May 2022

The pandemic is far from over: how can the private sector help us fight it?

We are still in the acute phase of the pandemic, with cases continuing to rise in many countries and vaccination rates stagnating. The private sector could play a key role in finally bringing COVID-19 under control.

Our impact

Syringe >888 million children immunised
First aid locator >15 million future deaths prevented
Transitioned 16 countries transitioned from Gavi support
Billions >230 US$ billion in economic benefits for countries (2000–2020)
Children 78% of the world's children reached by routine immunisation

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter